Plunkett Research Online: Ampio Pharmaceuticals Inc

AMPIO PHARMACEUTICALS INC (AMPE:ASE) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Ampio Pharmaceuticals, Inc. develops drugs to treat metabolic disease, eye disease, kidney disease, inflammation and CNS disease. The firm’s product pipeline includes certain FDA approved drugs, now targeted at new clinical indications protected by its intellectual property and new molecular entitie.....



Ampio Pharmaceuticals Inc
Ticker: AMPE
Exchange: ASE
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 720 437-6500
Fax: 720 437-6501
Address: 373 Inverness Parkway
Suite 200
Englewood, CO 80112 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
Contacts Description
Michael Macaluso CEO/Chairman of the Board/Director
Daniel Stokely CFO/Chief Accounting Officer/Secretary/Treasurer
See More
Ampio Pharmaceuticals, Inc. develops drugs to treat metabolic disease, eye disease, kidney disease, inflammation and CNS disease. The firm’s product pipeline includes certain FDA approved drugs, now targeted at new clinical indications protected by its intellectual property and new molecular entitie.....See More See More

Auditor: Moss Adams LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2019 2018 2017 2016 2015 2014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: